Johnson Pharma

Sun_02 May 2024

Trading

₹

+0.01 (+1.20%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Johnson Pharma

Johnson Pharma

Trading

Sun_02 May 2024

₹

+0.01 (+1.20%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
14-Oct-2021	S	Johnson Pharmacare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 14, 2021, inter alia, has recommended the proposal of sub-division of Company's 1 (one) equity shares of face value of Rs. 10/- each into 10 (ten) equity shares of face value of Rs 1/- each subject to approval by shareholders. Further to our letter dated 22nd November, 2021 informing your esteemed Exchange about a proposal being submitted to the shareholders through Postal Ballot Notice dated 14th October, 2021 seeking their approval for the split of the 5, 00,00,000 equity shares of Rs.10/- each into 50,00,00,000 equity shares of Rs.1/each, we wish to inform you that the shareholders have approved the proposal and the company has fixed 6th January,2022 as the Record Date for the said split of the shares. Thanking You. (As Per BSE Announcement Dated on 30.11.2021) Trading Members of the Exchange are hereby informed that JOHNSON PHARMACARE LTD., has fixed the Record Date for the purpose of sub division of equity shares of the company : DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE JOHNSON PHARMACARE LTD. (532154) RECORD DATE 06.01.2022 PURPOSE Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Ten equity shares of Rs. 1/- each. SUB-DIVIDED PAID-UP VALUE Rs.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 05/01/2022 DR- 192/2021-2022 Note:- i. ISIN No. INE560F01014 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 05/01/2022. ii. The new ISIN Number for Rs.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 14.12.2021) In Continuation of Notice No. 20211214-57 dated December 14, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: - Company Name & Scrip Code JOHNSON PHARMACARE LTD. (532154) New ISIN No. INE560F01022 Remarks Sub-division of equity shares from Rs.10/- to Rs.1/- The new ISIN number given above, for Equity Shares of Rs.1/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 05-01-2022 (DR-192/2021-2022) (As Per BSE Notice Dated 31.12.2021)	06-Jan-2022
24-Mar-2022	B	1:10 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, JOHNSON PHARMACARE LIMITED has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE JOHNSON PHARMACARE LIMITED (532154) RECORD DATE 08.04.2022 PURPOSE Issue of 1 (One) Bonus equity shares of Re.1/- each for every 10 (Ten) existing equity share of Re.1/- each held. Ex-Bonus basis from Date & Sett. No. 07/04/2022 DR-007/2022-2023 (As Per BSE Notice Dated on 04.04.2022)	08-Apr-2022	1:10
16-Jan-2024	BC	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI	22-Jan-2024
26-Oct-2023	BC	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI	01-Nov-2023
06-Sep-2023	BC	PFA PFA (As Per BSE Announcement dated on 28.09.2023)	28-Sep-2023
06-Sep-2023	BC	PFA	21-Sep-2023
03-Aug-2023	BC	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (L	10-Aug-2023

No Rights has been declared by Sun_

Book Closure

Record Date	Split Date	Purpose
22-Jan-2024	-	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI
01-Nov-2023	-	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI
28-Sep-2023	-	PFA PFA (As Per BSE Announcement dated on 28.09.2023)
21-Sep-2023	01 Jan'1900	PFA
10-Aug-2023	-	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (L

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Johnson Pharmacare Ltd ₹0.84(+0.01/1.20%)	0.84	+0.01	45.65	62.75	0.00	0.80
Computer Point Ltd ₹4.94(+0.31/6.70%)	4.94	+0.31	13.89	120.48	463.00	0.42
Ambalal Sarabhai Enterprises Ltd ₹46.50(+0.10/0.22%)	46.50	+0.10	355.58	106.59	0.00	9.77
Novartis India Ltd ₹1,036.55(+1.50/0.14%)	1,036.55	+1.50	2,555.62	74.25	26.75	3.64
Aegis Logistics Ltd ₹656.15(-30.15/-4.39%)	656.15	-30.15	24,089.13	74.12	54.60	10.85
Mysore Petro Chemicals Ltd ₹184.90(+1.35/0.74%)	184.90	+1.35	120.84	59.96	16.19	1.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.00	-1.55	0.04
Total Income	0.00	0.00	0.00	0.00	-1.55	0.04
Total Expenditure	0.00	0.00	0.19	0.08	0.01	0.08
PBIDT	0.00	0.00	-0.19	-0.08	-1.56	-0.04
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.00	0.00	-0.19	-0.08	-1.56	-0.04
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.00	0.00	-0.19	-0.08	-1.56	-0.04
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.00	0.00	-0.19	-0.08	-1.56	-0.04

EPS (Unit Curr.)	0.00	0.00	0.00	0.00	-0.03	0.00
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	-0.03	0.00
Calculated EPS (Unit Curr.)	0.00	0.00	0.00	0.00	-0.03	0.00
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	-0.03	0.00
Calculated EPS (Ann.) (Unit Curr.)	0.00	0.00	-0.01	-0.01	-0.11	0.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	-0.01	-0.01	-0.11	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	55.00	55.00	55.00	55.00	55.00	55.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	55.00	55.00	50.00	50.00	50.00	50.00
Reserves Total	1.95	3.24	8.14	8.14	8.21	8.23
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	56.95	58.24	58.14	58.14	58.21	58.23
Secured Loans	0.61	0.61	0.61	0.61	0.61	0.61
Unsecured Loans	1.30	0.00	0.08	0.02	1.09	1.09
Total Debt	1.91	0.61	0.69	0.63	1.70	1.70
Total Liabilities	58.86	58.85	58.83	58.77	59.91	59.93
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	45.56	54.18	52.26	52.26	53.13	54.03
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	1.05	1.68	0.92	0.92	0.00
Cash and Bank	0.00	0.04	0.23	0.28	0.30	0.33
Loans and Advances	0.00	0.00	3.69	3.69	3.95	3.95
Total Current Assets	0.00	1.09	5.60	4.89	5.17	4.28
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.98	1.13	0.65	0.00	0.00	0.00
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.98	1.13	0.65	0.00	0.00	0.00
Net Current Assets	-0.97	-0.04	4.95	4.88	5.17	4.28
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.02	0.02
Net Deferred Tax	0.00	0.00	0.00	0.00	-0.02	-0.02
Total Assets	44.59	54.14	57.21	57.14	58.28	58.29
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.04	0.23	0.28	0.30	0.33
Net Cash from Operating Activities	-0.40	4.90	-0.11	0.17	-0.93
Net Cash Used In Investing Activities	-0.94	-5.01	0.00	0.88	0.90
Net Cash Used In Financing Activities	1.30	-0.08	0.06	-1.07	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.04	-0.19	-0.05	-0.03	-0.03
Cash And Cash Equivalents At End Of The Year	0.00	0.04	0.23	0.28	0.30

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Johnson Pharmacare Ltd

Johnson Pharmacare Ltd is in the Trading sector, having a market capitalization of Rs. 45.65 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Ramanlal Trivedi,Pareshbhai Sengal,Manisha Maneklal Patel (Johnson Pharmacare Ltd) among others.

Chairman

Registered office

Office No 302 Munisuvrat Navg,NTC B-68 Swastik Society CG Rd,Ahmedabad,Gujarat,380009

FAX :

Background

Incorporation Year1994

Face Value₹1

Market Lot1

How to buy Johnson Pharma shares on nse?

To buy Johnson Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Johnson Pharma share price today?

The Johnson Pharma shares price on nse is Rs.0.84 today.

What is the market cap of Johnson Pharma shares on BSE ?

The company has a market capitalization of Rs.45.65Cr

What is the PE & PB ratio of Johnson Pharma shares ?

PE is 0 and PB is 0.8

What is the 52 Week High and Low of Johnson Pharma shares?

Johnson Pharma stock price high: Rs.1.38 Johnson Pharma stock price low: Rs.0.45